Similarly, Park et al. [136] reported that the expression of RIPK1, RIPK3, and MLKL is significantly downregulated in non-small cell lung cancer tissue (NSCLC) samples of a total of 253 NSCLC human patients (96 squamous cell carcinoma (SCC) cases and 157 adenocarcinomas (AC) cases); this downregulation was also positively correlated with worse prognosis. This evidence concerns the gene RIPK1 and non-small cell lung carcinoma.